Is Central Sensitization a Prognostic Indicator in Chronic Nonspecific Low Back Pain? | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Is Central Sensitization a Prognostic Indicator in Chronic Nonspecific Low Back Pain? | stella

Back to Chronic Nonspecific Low Back Pain trials

Recruiting

Plain-English translation of NCT07826546 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Trial locations(1 site)

Turkey (Türkiye)

Mardin Training and Research Hospital, Mardin

Key details

Sponsor

Mardin Artuklu University

Collaborators

Mardin Training and Research Hospital

Enrollment target

~180 participants

Started

June 2026

Primary completion

June 2027

Age range

18 Years – 65 Years

Last updated on clinicaltrials.gov in September 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Taha Yasin YILDIRIM, M.D.

Mardin Artuklu University

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.